CONSENT AND TERMINATION AGREEMENTConsent and Termination Agreement • September 13th, 2019 • Fibrocell Science, Inc. • Pharmaceutical preparations • Delaware
THIS CONSENT AND TERMINATION AGREEMENT (hereinafter referred to as this “Agreement”) is made and entered into as of September 12, 2019 by and among Castle Creek Pharmaceutical Holdings, Inc., a Delaware corporation (“Parent”), Fibrocell Science, Inc., a Delaware corporation (the “Company”), MSD Credit Opportunity Master Fund, L.P., a Cayman exempt limited partnership (the “Securityholder”), and Castle Creek Merger Corp., a Delaware corporation (“Merger Sub”).
COMPANY SECURITYHOLDER VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • September 13th, 2019 • Fibrocell Science, Inc. • Pharmaceutical preparations • Delaware
THIS COMPANY SECURITYHOLDER VOTING AND SUPPORT AGREEMENT (hereinafter referred to as this “Agreement”) is made and entered into as of September 12, 2019 by and between Castle Creek Pharmaceutical Holdings, Inc., a Delaware corporation (“Parent”), on the one hand, and the undersigned securityholders (collectively, the “Securityholders” and each individually, a “Securityholder”) of Fibrocell Science, Inc., a Delaware corporation (the “Company”), on the other hand.
